RxDoctor Payments Data

Kathryn Degoursey

Physician Assistant · Jacksonville, FLNPI 1659384766

Payments from drug & device makers

$6,755in general payments, 2019–2025

Across 288 payments — averaging $23.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$843
  • Merck$767
  • Amgen$765
  • Boehringer Ingelheim$611
  • Novo Nordisk$561
  • AstraZeneca$551
  • plus $3K from 29 others

What the payments were for

  • Food & beverage$6,60098%
  • Education$1552%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,755 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide131$184,969
XareltoRivaroxaban128$159,070
EntrestoSacubitril/Valsartan113$137,089
Repatha SureclickEvolocumab88$99,913
EliquisApixaban64$88,127
JardianceEmpagliflozin88$87,525
Repatha SyringeEvolocumab21$25,408
FarxigaDapagliflozin Propanediol22$20,065
Praluent PenAlirocumab15$18,273
VascepaIcosapent Ethyl24$16,532
BrilintaTicagrelor14$10,484
Ranolazine ErRanolazine59$8,028
Ezetimibe320$6,244
Dabigatran EtexilateDabigatran Etexilate Mesylate19$6,041
Rosuvastatin Calcium345$4,461

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$561$184,969131 claims
Johnson & JohnsonXarelto$312$159,070128 claims
NovartisEntresto$843$137,089113 claims
PfizerEliquis$289$88,12764 claims
Boehringer IngelheimJardiance$611$87,52588 claims
AstraZenecaFarxiga, Brilinta$551$30,54936 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →